Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1501
-
1502
-
1503
-
1504
-
1505
-
1506
-
1507
-
1508
<i>In vitro</i> application of ARTN decreased ATF3 expression in GFRα3-positive neurons.
Published 2013“…<p>In control conditions, most GFRα3-positive neurons expressed ATF3 at 1 d (96.7±0.5%) (<b><i>A–C</i></b>, arrows) and 4 d (97.2±0.4%) (<b><i>G–I</i></b>; arrows) after plating. …”
-
1509
-
1510
eNOS phosphorylation increased intracellular ROS generation and decreased cell viability in BH4-depleted cells.
Published 2015“…(C) eNOS phosphorylation decreased cellular viability in BH4-depleted cells. …”
-
1511
TSA administration decreases neuromuscular junction loss in <i>Smn<sup>2B/-</sup></i> mice.
Published 2014“…Note that whilst there is widespread NMJ pathology in vehicle treated mice, as evidence by full/partial denervation (white arrowhead/arrow respectively), NF accumulation (yellow arrow) and small, immature post-synaptic endplates, NMJs appear much more healthy in TSA treated mice, as evidenced by a decrease in denervation and NF accumulation, and an increase in post-synaptic size and maturity (scale bar = 50 µm). …”
-
1512
-
1513
-
1514
-
1515
-
1516
-
1517
Disrupting actin stress fibers decreases [Ca<sup>2+</sup>]<sub>i</sub> oscillation frequency.
Published 2013“…Scale bar = 50 μm. B) Representative fluorescence ratio (Em<sub>340</sub>/Em<sub>380</sub>) of a Fura-2-loaded cell over time is shown. …”
-
1518
-
1519
Pacritinib effectively decreases BTIC viability and sphere forming capacity and has on-target activity on phospho-STAT3.
Published 2017“…<p>(A) Pacritinib dramatically decreased cell viability in a dose dependent manner in eleven molecularly diverse patient-derived BTIC cultures with IC<sub>50</sub> values from 0.62 μM to 1.66 μM. …”
-
1520